Stocksigma LogoStocksigma Logo

Manipal Health Enterprises Delivers Strong Q2 FY27 Revenue and Operational Growth

Manipal Health Enterprises reported a 37.3% YoY rise in Q2 FY27 revenue from operations to ₹3,399.4 crore, with EBITDA climbing 29.8% YoY to ₹882.2 crore

Manipal Health Enterprises Delivers Strong Q2 FY27 Revenue and Operational Growth

Manipal Health Enterprises Ltd · Investor Presentation · 13 Nov 2026, 9:53 pm

Manipal Health Enterprises Delivers Strong Q2 FY27 Revenue and Operational Growth Manipal Health Enterprises reported a 37.3% YoY rise in Q2 FY27 revenue from operations to ₹3,399.4 crore, with EBITDA climbing 29.8% YoY to ₹882.2 crore at a 26.0% margin. Adjusted PAT (excluding exceptional items) increased 21.6% YoY to ₹380.2 crore, and rose 45.6% YoY to ₹455 crore excluding post-tax Sahyadri acquisition NCD interest. Inpatient volumes grew 35.0% to ~169,000, while occupancy improved 160 bps YoY to 70.1%. Ex-Sahyadri ARPOB rose 8.5% YoY to ₹76,600 per day. Net debt stood low at ₹343 crore.

Original exchange filing (PDF)

More announcements from Manipal Health Enterprises Ltd

All Manipal Health Enterprises Ltd announcements